Vulnerability · CVE-2026-39966
TypeBot is a chatbot builder tool.
Published May 22, 2026 · catalog updated Jul 23, 2026 · TypeBot is a chatbot
Check if you run it
No confirmed exploitation is on record for CVE-2026-39966. EPSS is 0.44%. Act only if a listed version of TypeBot is a chatbot is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (TypeBot is a chatbot).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium6.5
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.44%
- Remediation
- Advisory link
- Affected products
- See sources for product scope
TypeBot is a chatbot builder tool. In versions 3.15.2, the getLinkedTypebots API endpoint returns full bot definitions to any authenticated user who references a target bot ID in a Typebot Link block, regardless of workspace ownership, leading to IDOR. The authorization check uses Array.filter() with an async callback — since filter() is synchronous, the callback always returns a truthy Promise, so the access control predicate is never actually evaluated. Any authenticated Typebot user can read the full definition of any other workspace's private bots, including: all conversation blocks and logic flow, variable values embedded in the bot (credentials, API keys, PII), webhook URLs and integration configurations. This issue has been fixed in version 3.16.0.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2026-39966
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-39966. EPSS is 0.44%. Act only if a listed version of TypeBot is a chatbot is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-863: Incorrect Authorization. EPSS 0.44%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
May 22, 2026 · NIST NVD
Detected
TypeBot is a chatbot builder tool. In versions 3.15.2, the getLinkedTypebots API endpoint returns full bot definitions to any authenticated user who references a target bot ID in a Typebot Link block, regardless of workspace ownership, leading to IDOR. The authorization check uses Array.filter() with an async callback — since filter() is synchronous, the callback always returns a truthy Promise, s
Jul 23, 2026 · NIST NVD
Updated
TypeBot is a chatbot builder tool. In versions 3.15.2, the getLinkedTypebots API endpoint returns full bot definitions to any authenticated user who references a target bot ID in a Typebot Link block, regardless of workspace ownership, leading to IDOR. The authorization check uses Array.filter() with an async callback — since filter() is synchronous, the callback always returns a truthy Promise, s
Sources
- CVE.orgVulnerability recordCVE-2026-39966
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-39966
30-day exploitation probability 0.4%
first.org - NIST NVDVulnerability recordCVE-2026-39966
TypeBot is a chatbot builder tool. In versions 3.15.2, the getLinkedTypebots API endpoint returns full bot definitions to any authenticated user who references a target bot ID in a Typebot Link block, regardless of workspace ownership, leading to IDOR. The authorization check use
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.